Dr. Skinner will help ensure the AMR Action Fund achieves its mission to bring two to four new antibiotics to patients by the end of the decade and facilitate needed long-term policy solutions FEBRUARY 18, 2021, BOSTON, MA — Today, the AMR Action Fund announced the appointment of its first Chief Executive Officer (CEO), Henry...
Read morePatients, Civil Society and Youth Organisations, Products Development Partnerships, Health and Pharmaceutical Industries, and all stakeholders who are striving to improve global public health – welcome the African Medicines Agency (AMA) Treaty made at the 32nd ordinary session of the Assembly of the African Union (AU) in 2019. We now call for all AU Member...
Read moreOn the eve of the 34th African Union Summit, two years after the Treaty to establish an African Medicines Agency was agreed, over 40 leading organizations who represent hundreds of thousands of patients, product development partnerships, youth groups, researchers and industry leaders, are urging Heads of State and Government to ratify the Treaty as a matter of priority. Delaying the establishment of an African Medicines Agency (AMA) undermines the timely access to effective, quality therapies, and vaccines for all patients across Africa.
Read moreWe call upon all countries to ratify the AMA Treaty to enable the operational implementation of the continental regulatory system that will benefit patients, regulators, industry and healthcare systems in Africa.
Read more
Global supply chains are key to delivering vaccines to protect citizens against COVID-19. The making of a vaccine requires many dozens of ingredients and manufacturing components which come from around the world. It is vital that any measures proposed by the European Commission and the Member States do not restrict, hold back, or have other...
Read moreGeneva, 25 January 2021 –The biopharmaceutical global industry, represented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), is pleased to announce that Jean-Christophe Tellier, UCB Chief Executive Officer & Chairman of the Executive Committee has assumed the role of IFPMA President. Jean-Christophe Tellier succeeds David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly...
Read moreMr Chairman, IFPMA welcomes and supports the ongoing work and interim findings of the Review Committee on the Functioning of the IHR during the COVID-19 Response. Many critical issues have arisen through the Committee’s review process and it would be impossible for us to address all of these in the short amount of time we...
Read moreWe share the deep sense of responsibility that together we have to end this pandemic and are proud to be a founding member of the ACT A. We are keenly aware that science and innovation are only part of the equation. As part of our responsibility towards society, we must also ensure equitable global access...
Read moreIFPMA, PhRMA, EFPIA, Vaccines Europe, BIO, ICBA Statement With the first COVID-19 vaccines authorized by regulatory authorities and administered to the public, the biopharmaceutical industry, including leading vaccine makers, recognize that a critical new phase of the COVID-19 pandemic has begun. Collaboration among the global community has resulted in safe and efficacious vaccines being authorized...
Read moreThe Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme to provide young entrepreneurs in the healthcare sector an opportunity to develop their business ideas and advance promising solutions to support, equip, protect, and train healthcare workers. Applications open from 11 January and close on 31 March 2021. The Award...
Read more